questionsmedicales.fr
Phénomènes microbiologiques
Phénomènes physiologiques viraux
Réplication virale
Activation virale
Activation virale : Questions médicales fréquentes
Termes MeSH sélectionnés :
Diagnostic
5
Diagnostic
Infections virales
Tests de diagnostic
Virus
Symptômes
Infections virales
Biopsie
Infections virales
Symptômes
5
Symptômes
Infections virales
Complications
Infections virales
Symptômes
Maladies infectieuses
Prévention
5
Hygiène
Infections virales
Masques
Prévention des maladies
Voyages
Infections virales
Comportements à risque
Infections virales
Traitements
5
Traitement antiviral
Infections virales
Antibiotiques
Infections virales
Vaccins
Prévention des maladies
Complications
5
Complications
Infections virales
Maladies chroniques
Infections virales
Complications
État de santé
Gestion des complications
Infections virales
Facteurs de risque
5
Facteurs de risque
Infections virales
Maladies chroniques
Infections virales
Mode de vie
Infections virales
Stress
Infections virales
{
"@context": "https://schema.org",
"@graph": [
{
"@type": "MedicalWebPage",
"name": "Activation virale : Questions médicales les plus fréquentes",
"headline": "Activation virale : Comprendre les symptômes, diagnostics et traitements",
"description": "Guide complet et accessible sur les Activation virale : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.",
"datePublished": "2024-03-12",
"dateModified": "2025-03-07",
"inLanguage": "fr",
"medicalAudience": [
{
"@type": "MedicalAudience",
"name": "Grand public",
"audienceType": "Patient",
"healthCondition": {
"@type": "MedicalCondition",
"name": "Activation virale"
},
"suggestedMinAge": 18,
"suggestedGender": "unisex"
},
{
"@type": "MedicalAudience",
"name": "Médecins",
"audienceType": "Physician",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "France"
}
},
{
"@type": "MedicalAudience",
"name": "Chercheurs",
"audienceType": "Researcher",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "International"
}
}
],
"reviewedBy": {
"@type": "Person",
"name": "Dr Olivier Menir",
"jobTitle": "Expert en Médecine",
"description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale",
"url": "/static/pages/docteur-olivier-menir.html",
"alumniOf": {
"@type": "EducationalOrganization",
"name": "Université Paris Descartes"
}
},
"isPartOf": {
"@type": "MedicalWebPage",
"name": "Réplication virale",
"url": "https://questionsmedicales.fr/mesh/D014779",
"about": {
"@type": "MedicalCondition",
"name": "Réplication virale",
"code": {
"@type": "MedicalCode",
"code": "D014779",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "G06.920.925"
}
}
},
"about": {
"@type": "MedicalCondition",
"name": "Activation virale",
"alternateName": "Virus Activation",
"code": {
"@type": "MedicalCode",
"code": "D014775",
"codingSystem": "MeSH"
}
},
"author": [
{
"@type": "Person",
"name": "Duncan R Smith",
"url": "https://questionsmedicales.fr/author/Duncan%20R%20Smith",
"affiliation": {
"@type": "Organization",
"name": "Institute of Molecular Biosciences, Mahidol University, Salaya 73170, Thailand."
}
},
{
"@type": "Person",
"name": "Atitaya Hitakarun",
"url": "https://questionsmedicales.fr/author/Atitaya%20Hitakarun",
"affiliation": {
"@type": "Organization",
"name": "Institute of Molecular Biosciences, Mahidol University, Salaya 73170, Thailand."
}
},
{
"@type": "Person",
"name": "Ryosuke Morimoto",
"url": "https://questionsmedicales.fr/author/Ryosuke%20Morimoto",
"affiliation": {
"@type": "Organization",
"name": "Department of Health and Nutrition, Faculty of Human Life Science, Shikoku University, Tokushima 771-1192, Japan."
}
},
{
"@type": "Person",
"name": "Yuji Isegawa",
"url": "https://questionsmedicales.fr/author/Yuji%20Isegawa",
"affiliation": {
"@type": "Organization",
"name": "Department of Applied Biological Chemistry, Graduate School of Agriculture, Osaka Metropolitan University, Sakai, Osaka 599-8531, Japan."
}
},
{
"@type": "Person",
"name": "Janejira Jaratsittisin",
"url": "https://questionsmedicales.fr/author/Janejira%20Jaratsittisin",
"affiliation": {
"@type": "Organization",
"name": "Institute of Molecular Biosciences, Mahidol University, Salaya 73170, Thailand."
}
}
],
"citation": [
{
"@type": "ScholarlyArticle",
"name": "[Mesenteric venous thrombosis].",
"datePublished": "2023-02-26",
"url": "https://questionsmedicales.fr/article/36849315",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1016/j.medcli.2023.01.020"
}
},
{
"@type": "ScholarlyArticle",
"name": "[Tumor-associated thrombosis].",
"datePublished": "2023-08-23",
"url": "https://questionsmedicales.fr/article/37611569",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1055/a-1941-7132"
}
},
{
"@type": "ScholarlyArticle",
"name": "Pediatric arterial thrombosis: A single-institution cohort study of patient characteristics and thrombosis outcomes.",
"datePublished": "2023-10-30",
"url": "https://questionsmedicales.fr/article/37902500",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1002/pbc.30756"
}
},
{
"@type": "ScholarlyArticle",
"name": "Evaluation of Patients with Neonatal Thrombosis.",
"datePublished": "2023-03-02",
"url": "https://questionsmedicales.fr/article/36859514",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1007/s12098-023-04497-w"
}
},
{
"@type": "ScholarlyArticle",
"name": "Platelet-Neutrophil Crosstalk in Thrombosis.",
"datePublished": "2023-01-09",
"url": "https://questionsmedicales.fr/article/36674781",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.3390/ijms24021266"
}
}
],
"breadcrumb": {
"@type": "BreadcrumbList",
"itemListElement": [
{
"@type": "ListItem",
"position": 1,
"name": "questionsmedicales.fr",
"item": "https://questionsmedicales.fr"
},
{
"@type": "ListItem",
"position": 2,
"name": "Phénomènes microbiologiques",
"item": "https://questionsmedicales.fr/mesh/D008827"
},
{
"@type": "ListItem",
"position": 3,
"name": "Phénomènes physiologiques viraux",
"item": "https://questionsmedicales.fr/mesh/D018406"
},
{
"@type": "ListItem",
"position": 4,
"name": "Réplication virale",
"item": "https://questionsmedicales.fr/mesh/D014779"
},
{
"@type": "ListItem",
"position": 5,
"name": "Activation virale",
"item": "https://questionsmedicales.fr/mesh/D014775"
}
]
}
},
{
"@type": "MedicalWebPage",
"name": "Article complet : Activation virale - Questions et réponses",
"headline": "Questions et réponses médicales fréquentes sur Activation virale",
"description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.",
"datePublished": "2025-05-01",
"inLanguage": "fr",
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Diagnostic",
"headline": "Diagnostic sur Activation virale",
"description": "Comment diagnostiquer une activation virale ?\nQuels tests sont utilisés pour détecter les virus activés ?\nLes symptômes aident-ils au diagnostic ?\nPeut-on détecter un virus inactif ?\nLes biopsies sont-elles utiles pour le diagnostic ?",
"url": "https://questionsmedicales.fr/mesh/D014775?mesh_terms=Thrombosis#section-diagnostic"
},
{
"@type": "MedicalWebPage",
"name": "Symptômes",
"headline": "Symptômes sur Activation virale",
"description": "Quels sont les symptômes d'une activation virale ?\nLes symptômes varient-ils selon le virus ?\nL'activation virale cause-t-elle des complications ?\nLes symptômes apparaissent-ils rapidement ?\nPeut-on avoir des symptômes sans activation virale ?",
"url": "https://questionsmedicales.fr/mesh/D014775?mesh_terms=Thrombosis#section-symptômes"
},
{
"@type": "MedicalWebPage",
"name": "Prévention",
"headline": "Prévention sur Activation virale",
"description": "Comment prévenir l'activation virale ?\nLe lavage des mains aide-t-il à prévenir les infections ?\nLes masques protègent-ils contre les virus ?\nLes voyages augmentent-ils le risque d'activation virale ?\nLes comportements à risque augmentent-ils l'activation virale ?",
"url": "https://questionsmedicales.fr/mesh/D014775?mesh_terms=Thrombosis#section-prévention"
},
{
"@type": "MedicalWebPage",
"name": "Traitements",
"headline": "Traitements sur Activation virale",
"description": "Quels traitements existent pour l'activation virale ?\nLes antibiotiques sont-ils efficaces contre les virus ?\nLes vaccins aident-ils à prévenir l'activation virale ?\nComment les antiviraux agissent-ils ?\nLes traitements sont-ils les mêmes pour tous les virus ?",
"url": "https://questionsmedicales.fr/mesh/D014775?mesh_terms=Thrombosis#section-traitements"
},
{
"@type": "MedicalWebPage",
"name": "Complications",
"headline": "Complications sur Activation virale",
"description": "Quelles sont les complications possibles d'une activation virale ?\nL'activation virale peut-elle entraîner des maladies chroniques ?\nLes complications sont-elles prévisibles ?\nLes enfants sont-ils plus à risque de complications ?\nComment gérer les complications d'une activation virale ?",
"url": "https://questionsmedicales.fr/mesh/D014775?mesh_terms=Thrombosis#section-complications"
},
{
"@type": "MedicalWebPage",
"name": "Facteurs de risque",
"headline": "Facteurs de risque sur Activation virale",
"description": "Quels sont les facteurs de risque d'activation virale ?\nL'âge influence-t-il le risque d'activation virale ?\nLes maladies chroniques augmentent-elles le risque ?\nLe mode de vie affecte-t-il le risque d'activation virale ?\nLe stress psychologique influence-t-il le risque ?",
"url": "https://questionsmedicales.fr/mesh/D014775?mesh_terms=Thrombosis#section-facteurs de risque"
}
]
},
{
"@type": "FAQPage",
"mainEntity": [
{
"@type": "Question",
"name": "Comment diagnostiquer une activation virale ?",
"position": 1,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des tests sanguins et des cultures virales peuvent confirmer l'activation."
}
},
{
"@type": "Question",
"name": "Quels tests sont utilisés pour détecter les virus activés ?",
"position": 2,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les tests PCR et les sérologies sont couramment utilisés pour détecter les virus."
}
},
{
"@type": "Question",
"name": "Les symptômes aident-ils au diagnostic ?",
"position": 3,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les symptômes cliniques orientent souvent vers une activation virale."
}
},
{
"@type": "Question",
"name": "Peut-on détecter un virus inactif ?",
"position": 4,
"acceptedAnswer": {
"@type": "Answer",
"text": "Non, les tests ne détectent que les virus actifs ou en phase de réplication."
}
},
{
"@type": "Question",
"name": "Les biopsies sont-elles utiles pour le diagnostic ?",
"position": 5,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les biopsies peuvent aider à identifier des infections virales localisées."
}
},
{
"@type": "Question",
"name": "Quels sont les symptômes d'une activation virale ?",
"position": 6,
"acceptedAnswer": {
"@type": "Answer",
"text": "Fièvre, fatigue, douleurs musculaires et éruptions cutanées sont fréquents."
}
},
{
"@type": "Question",
"name": "Les symptômes varient-ils selon le virus ?",
"position": 7,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, chaque virus peut provoquer des symptômes spécifiques et variés."
}
},
{
"@type": "Question",
"name": "L'activation virale cause-t-elle des complications ?",
"position": 8,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, elle peut entraîner des complications graves comme des pneumonies ou des encéphalites."
}
},
{
"@type": "Question",
"name": "Les symptômes apparaissent-ils rapidement ?",
"position": 9,
"acceptedAnswer": {
"@type": "Answer",
"text": "Ils peuvent apparaître rapidement ou après une période d'incubation prolongée."
}
},
{
"@type": "Question",
"name": "Peut-on avoir des symptômes sans activation virale ?",
"position": 10,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, d'autres maladies peuvent provoquer des symptômes similaires sans activation virale."
}
},
{
"@type": "Question",
"name": "Comment prévenir l'activation virale ?",
"position": 11,
"acceptedAnswer": {
"@type": "Answer",
"text": "La vaccination, l'hygiène et l'évitement des contacts sont essentiels."
}
},
{
"@type": "Question",
"name": "Le lavage des mains aide-t-il à prévenir les infections ?",
"position": 12,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, un bon lavage des mains réduit le risque de transmission virale."
}
},
{
"@type": "Question",
"name": "Les masques protègent-ils contre les virus ?",
"position": 13,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les masques peuvent réduire la transmission des virus respiratoires."
}
},
{
"@type": "Question",
"name": "Les voyages augmentent-ils le risque d'activation virale ?",
"position": 14,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les voyages peuvent exposer à de nouveaux virus et augmenter le risque."
}
},
{
"@type": "Question",
"name": "Les comportements à risque augmentent-ils l'activation virale ?",
"position": 15,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des comportements comme le partage d'aiguilles augmentent le risque d'infection."
}
},
{
"@type": "Question",
"name": "Quels traitements existent pour l'activation virale ?",
"position": 16,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les antiviraux, les immunomodulateurs et les soins de soutien sont utilisés."
}
},
{
"@type": "Question",
"name": "Les antibiotiques sont-ils efficaces contre les virus ?",
"position": 17,
"acceptedAnswer": {
"@type": "Answer",
"text": "Non, les antibiotiques ne sont pas efficaces contre les infections virales."
}
},
{
"@type": "Question",
"name": "Les vaccins aident-ils à prévenir l'activation virale ?",
"position": 18,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les vaccins peuvent prévenir certaines infections virales et leur activation."
}
},
{
"@type": "Question",
"name": "Comment les antiviraux agissent-ils ?",
"position": 19,
"acceptedAnswer": {
"@type": "Answer",
"text": "Ils inhibent la réplication virale, réduisant ainsi la charge virale dans l'organisme."
}
},
{
"@type": "Question",
"name": "Les traitements sont-ils les mêmes pour tous les virus ?",
"position": 20,
"acceptedAnswer": {
"@type": "Answer",
"text": "Non, chaque virus peut nécessiter un traitement spécifique adapté."
}
},
{
"@type": "Question",
"name": "Quelles sont les complications possibles d'une activation virale ?",
"position": 21,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des complications comme la pneumonie, l'encéphalite ou des infections secondaires peuvent survenir."
}
},
{
"@type": "Question",
"name": "L'activation virale peut-elle entraîner des maladies chroniques ?",
"position": 22,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, certaines infections virales peuvent provoquer des maladies chroniques comme l'hépatite."
}
},
{
"@type": "Question",
"name": "Les complications sont-elles prévisibles ?",
"position": 23,
"acceptedAnswer": {
"@type": "Answer",
"text": "Certaines complications peuvent être prévisibles selon le virus et l'état de santé de l'hôte."
}
},
{
"@type": "Question",
"name": "Les enfants sont-ils plus à risque de complications ?",
"position": 24,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les enfants peuvent être plus vulnérables à certaines complications virales."
}
},
{
"@type": "Question",
"name": "Comment gérer les complications d'une activation virale ?",
"position": 25,
"acceptedAnswer": {
"@type": "Answer",
"text": "Un suivi médical régulier et des traitements appropriés sont essentiels pour gérer les complications."
}
},
{
"@type": "Question",
"name": "Quels sont les facteurs de risque d'activation virale ?",
"position": 26,
"acceptedAnswer": {
"@type": "Answer",
"text": "L'immunodépression, le stress et les voyages fréquents augmentent le risque."
}
},
{
"@type": "Question",
"name": "L'âge influence-t-il le risque d'activation virale ?",
"position": 27,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les personnes âgées et les jeunes enfants sont plus à risque."
}
},
{
"@type": "Question",
"name": "Les maladies chroniques augmentent-elles le risque ?",
"position": 28,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des maladies comme le diabète ou le VIH augmentent le risque d'activation virale."
}
},
{
"@type": "Question",
"name": "Le mode de vie affecte-t-il le risque d'activation virale ?",
"position": 29,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, un mode de vie sain peut réduire le risque d'activation virale."
}
},
{
"@type": "Question",
"name": "Le stress psychologique influence-t-il le risque ?",
"position": 30,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, le stress peut affaiblir le système immunitaire et augmenter le risque d'infection."
}
}
]
}
]
}
Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale
Validation scientifique effectuée le 07/03/2025
Contenu vérifié selon les dernières recommandations médicales
5 publications dans cette catégorie
Affiliations :
Institute of Molecular Biosciences, Mahidol University, Salaya 73170, Thailand.
Publications dans "Activation virale" :
4 publications dans cette catégorie
Affiliations :
Institute of Molecular Biosciences, Mahidol University, Salaya 73170, Thailand.
Publications dans "Activation virale" :
3 publications dans cette catégorie
Affiliations :
Department of Health and Nutrition, Faculty of Human Life Science, Shikoku University, Tokushima 771-1192, Japan.
Publications dans "Activation virale" :
3 publications dans cette catégorie
Affiliations :
Department of Applied Biological Chemistry, Graduate School of Agriculture, Osaka Metropolitan University, Sakai, Osaka 599-8531, Japan.
Publications dans "Activation virale" :
3 publications dans cette catégorie
Affiliations :
Institute of Molecular Biosciences, Mahidol University, Salaya 73170, Thailand.
Publications dans "Activation virale" :
3 publications dans cette catégorie
Affiliations :
Institute of Molecular Biosciences, Mahidol University, Salaya 73170, Thailand.
Publications dans "Activation virale" :
3 publications dans cette catégorie
Affiliations :
National Center for Genetic Engineering and Biotechnology (BIOTEC), National Science and Technology Development Agency, Pathum Thani, 12120, Thailand.
Publications dans "Activation virale" :
3 publications dans cette catégorie
Affiliations :
Laboratory of Molecular RNA Virology and Antiviral Strategies, Department of Microbiology, Yong Loo Lin School of Medicine, National University Health System, National University of Singapore, Singapore.
Publications dans "Activation virale" :
3 publications dans cette catégorie
Affiliations :
Laboratory of Molecular RNA Virology and Antiviral Strategies, Department of Microbiology, Yong Loo Lin School of Medicine, National University Health System, National University of Singapore, Singapore; Institute of Molecular and Cell Biology, Agency for Science, Technology and Research (A*STAR), Singapore. Electronic address: miccjh@nus.edu.sg.
Publications dans "Activation virale" :
2 publications dans cette catégorie
Affiliations :
Institute of Molecular Biosciences, Mahidol University, Salaya 73170, Thailand.
Publications dans "Activation virale" :
2 publications dans cette catégorie
Affiliations :
Department of Clinical and Biological Sciences, Laboratory of Molecular Virology and Antiviral Research, University of Turin, S. Luigi Gonzaga Hospital, Orbassano Turin, Italy.
Publications dans "Activation virale" :
2 publications dans cette catégorie
Affiliations :
Department of Clinical and Biological Sciences, Laboratory of Molecular Virology and Antiviral Research, University of Turin, S. Luigi Gonzaga Hospital, Orbassano Turin, Italy.
Publications dans "Activation virale" :
2 publications dans cette catégorie
Affiliations :
Department of Clinical and Biological Sciences, Laboratory of Molecular Virology and Antiviral Research, University of Turin, S. Luigi Gonzaga Hospital, Orbassano Turin, Italy.
Publications dans "Activation virale" :
2 publications dans cette catégorie
Affiliations :
Department of Clinical and Biological Sciences, Laboratory of Molecular Virology and Antiviral Research, University of Turin, S. Luigi Gonzaga Hospital, Orbassano Turin, Italy. Electronic address: david.lembo@unito.it.
Publications dans "Activation virale" :
2 publications dans cette catégorie
Affiliations :
Department of Pharmacognosy, College of Pharmacy, King Saud University, Riyadh 11451, Kingdom of Saudi Arabia.
Publications dans "Activation virale" :
2 publications dans cette catégorie
Affiliations :
Department of Pharmacognosy, College of Pharmacy, King Saud University, Riyadh 11451, Kingdom of Saudi Arabia.
Publications dans "Activation virale" :
2 publications dans cette catégorie
Affiliations :
Centre for Global Health Research, University of Edinburgh, Edinburgh, UK.
Publications dans "Activation virale" :
2 publications dans cette catégorie
Publications dans "Activation virale" :
2 publications dans cette catégorie
Affiliations :
College of Veterinary Medicine, Yangzhou University, Yangzhou, 225009, Jiangsu Province, PR China; Institute of Comparative Medicine, Yangzhou University, Yangzhou, 225009, Jiangsu Province, PR China.
Publications dans "Activation virale" :
2 publications dans cette catégorie
Affiliations :
Animal Infectious Disease Laboratory, College of Veterinary Medicine, Yangzhou University, Yangzhou, 225009, PR China; Jiangsu Co-innovation Center for Prevention and Control of Important Animal Infectious Diseases and Zoonosis, Yangzhou University, Yangzhou, 225009, Jiangsu Province, PR China.
Publications dans "Activation virale" :
Mesenteric vein thrombosis (MVT) is a rare condition that can present acutely, subacutely, or chronically. MVT can be isolated or within a splanchnic thrombosis (spleno-porto-mesenteric). Symptomatic ...
The evidence available today from randomized controlled trials shows that for many patients with CAT, direct FXa-inhibitors are a safer and potentially more effective therapy than long-term treatment ...
Arterial thrombosis (AT) is an increasingly recognized complication in pediatrics. Consensus clinical practice guidelines suggest immediate removal of the indwelling arterial catheter and a short cour...
Describe treatment patterns and outcomes in pediatric patients with AT and explore predictors for complete thrombus resolution or long-term complications....
Single-institution retrospective study. Patients were identified by ICD-9 and ICD-10 codes for the diagnosis of AT or reports of AT on ultrasound from January 1, 2012, to October 1, 2022. Descriptive ...
101 patients were included. The median age was 2.2 months. The most common underlying diagnoses were congenital heart disease (39.6%) and infection (22.8%). A majority of patients had symptomatic thro...
Duration of anticoagulation was widely variable, and 70% of patients achieved complete resolution by 90 days of anticoagulation. A significant proportion of patients developed long-term sequelae secon...
The aim of the study is to characterize acquired and genetic risk factors and to give an account of the hereditary thrombophilia panel in neonatal thrombosis. All newborns diagnosed with neonatal thro...
Platelets are essential for the formation of a haemostatic plug to prevent bleeding, while neutrophils are the guardians of our immune defences against invading pathogens. The interplay between platel...
Cancer and coronavirus disease 2019 (COVID-19) have unusual similarities: they both result in a markedly elevated risk of thrombosis, exceptionally high D-dimer levels, and the failure of anticoagulat...
The risk of cardiovascular events caused by acute thrombosis is high, including acute myocardial infarction, acute stroke, acute pulmonary embolism, and deep vein thrombosis. In this review, we summar...
Thrombosis is a common disorder with a relevant burden of morbidity and mortality worldwide, particularly among elderly patients. Growing evidence demonstrated a direct role of oxidative stress in thr...
Venous (VTE) and arterial (ATE) thromboemboli are a leading cause of morbidity and mortality in patients with cancer. Patients with hematological malignancies are at an exceptionally high risk of both...
Endovascular treatment (EVT) for cerebral vein thrombosis (CVT) has not been proven to be more effective than anticoagulation based on recent results of the Thrombolysis or Anticoagulation for Cerebra...
To compare outcomes of EVT vs medical management in CVT....
We compared EVT vs medical management in a retrospective multinational cohort of consecutive patients with CVT across 4 countries (USA, Italy, Switzerland, and New Zealand) and 27 sites (2015-2020), u...
Of the 987 patients, the mean age was 45.7 ± 16.9 years and 79 (8%) underwent EVT. With PSM (n = 124), there were no major differences in clinical or imaging features between groups other than a highe...
In this large observational cohort, there was no evidence of benefit with EVT for CVT. These findings corroborate the results from the TO-ACT trial....